Lose the noise. Keep the results

Semaglutide: A medically guided option for appetite control, steady progress, and long-term weight management

At Calorie Counter in Owasso, we offer medically supervised weight loss programs designed to help patients lose weight safely, confidently, and with real support. One of the most requested options is semaglutide, a prescription medication that works by supporting appetite regulation, improving satiety, and helping many patients stay more consistent with their nutrition plan over time. Semaglutide is used alongside a reduced-calorie diet and increased physical activity, not as a stand-alone shortcut.

Whether you feel like you are constantly hungry, struggle with portion control, battle cravings, or have hit a plateau with diet and exercise alone, our team can help determine whether semaglutide may be an appropriate part of your treatment plan.

Your Questions, Answered.

  • Semaglutide is a GLP-1 receptor agonist. This class of medication works by mimicking a naturally occurring hormone involved in appetite regulation, blood sugar response, and gastric emptying. In appropriate patients, semaglutide can help reduce hunger, increase fullness after meals, and support more sustainable calorie control.

    For chronic weight management, FDA-approved semaglutide products are indicated for adults with obesity, or for adults who are overweight with at least one weight-related condition. Wegovy is also approved to reduce the risk of major cardiovascular events in certain adults with cardiovascular disease and obesity or overweight.

  • Semaglutide supports weight loss by helping patients:

    • feel full sooner

    • stay satisfied longer

    • reduce frequent hunger cues

    • improve control over cravings and snacking

    • stay more consistent with a structured nutrition plan

    Because semaglutide helps regulate appetite and slows gastric emptying, many patients find it easier to maintain portion control and follow a lower-calorie plan.

  • A provider-guided semaglutide program may help eligible patients:

    • reduce appetite

    • improve fullness after meals

    • support steady weight loss over time

    • improve adherence to a nutrition plan

    • build better long-term habits with medical oversight

    The best results typically happen when medication is paired with nutrition guidance, activity, follow-up care, and realistic lifestyle changes. FDA labeling specifically describes semaglutide for weight management as an adjunct to reduced-calorie eating and increased physical activity.

  • You may be a candidate for semaglutide if you:

    • have a BMI in the obesity range

    • are overweight and also have weight-related health concerns

    • struggle with persistent appetite, overeating, or cravings

    • have not had success with diet and exercise alone

    • want a medically supervised approach instead of guessing on your own

    Your provider will review your medical history, medications, symptoms, goals, and risk factors to determine whether semaglutide is appropriate and safe for you. FDA-approved use for chronic weight management is based on BMI criteria and, in some cases, the presence of weight-related comorbidities.

  • Our semaglutide program is designed to be supportive, structured, and realistic.

    Your visit may include:

    • a medical evaluation

    • review of your health history and current medications

    • discussion of your weight loss goals

    • provider guidance on whether semaglutide is a fit

    • dosing education

    • follow-up monitoring

    • lifestyle recommendations to support your results

    We believe weight loss works better when patients feel informed, encouraged, and closely supported throughout the process.

  • Every patient is different. Some people notice appetite changes early, while visible weight loss may take longer and depends on consistency, dose progression, food choices, activity, sleep, and other health factors. Because semaglutide is typically titrated upward over several months, progress often builds over time rather than all at once.

    We encourage patients to focus on:

    • reduced hunger

    • better control around food

    • improved consistency

    • steady progress instead of perfection

It’s Not You, It’s Your Hormones

  • Semaglutide is typically started at a low dose and increased gradually over time to improve tolerability. For weekly injectable semaglutide used for weight management, the standard escalation commonly begins at 0.25 mg once weekly for 4 weeks, then gradually increases in 4-week intervals toward a maintenance dose, depending on the product and patient tolerance.

    Your provider will determine:

    • your starting dose

    • when to increase your dose

    • whether your body is tolerating treatment well

    • when to hold, continue, or adjust your program

    Dose changes should always be guided by a licensed medical provider.

    For chronic weight management, FDA-approved semaglutide products are indicated for adults with obesity, or for adults who are overweight with at least one weight-related condition. Wegovy is also approved to reduce the risk of major cardiovascular events in certain adults with cardiovascular disease and obesity or overweight.

  • Like any prescription medication, semaglutide can cause side effects. Common side effects may include:

    • nausea

    • vomiting

    • diarrhea

    • constipation

    • abdominal discomfort

    • decreased appetite

    These effects are one reason the medication is increased gradually over time.

  • Semaglutide is not right for everyone. It carries a boxed warning regarding the risk of thyroid C-cell tumors observed in rodents, and it should not be used in patients with a personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

    Patients should also discuss a history of:

    • pancreatitis

    • gallbladder problems

    • kidney issues

    • diabetic retinopathy

    • pregnancy or plans to become pregnant

    • severe gastrointestinal symptoms

    • other medications that may affect treatment safety

    A provider visit is required to determine candidacy and ensure safe prescribing.

Semaglutide FAQ

 

What is semaglutide used for?

Semaglutide is used in FDA-approved products for chronic weight management in certain adults with obesity or overweight, and in other products for type 2 diabetes management and certain cardiovascular risk reduction indications.

Is semaglutide the same as Ozempic?

Ozempic contains semaglutide, but it is FDA-approved for type 2 diabetes and cardiovascular risk reduction in certain adults with type 2 diabetes. Wegovy is the FDA-approved semaglutide brand for chronic weight management.

How often do you take semaglutide?

Injectable semaglutide products referenced here are generally taken once weekly, with dose escalation guided by a provider.

Do I still need to diet and exercise?

Yes. Semaglutide is intended to be used with a reduced-calorie diet and increased physical activity.

Who should not take semaglutide?

People with certain thyroid cancer risk histories, including personal or family history of medullary thyroid carcinoma or MEN 2, should not use semaglutide. Other medical conditions may also affect eligibility.

Are results guaranteed?

No. Results vary from person to person and depend on medical history, consistency, dose progression, nutrition, and lifestyle factors.

Ready to get started?

If you’re looking for semaglutide in Owasso, OK, our team at Calorie Counter can help you determine whether this option fits your goals and medical history. Schedule a visit to meet with a provider, review your options, and build a personalized weight loss plan with real support.

call now
call now